2012 ©
             Publication
Journal Publication
Title of Article Repression of Nrf2 enhances antitumor effect of 5-fluorouracil and gemcitabine on cholangiocarcinoma cells 
Date of Acceptance 2 February 2015 
Journal
     Title of Journal Naunyn-Schmiedeberg's Archives of Pharmacology 
     Standard ISI 
     Institute of Journal Springer International Publishing AG, Part of Springer Science+Business Media 
     ISBN/ISSN 0028-1298 
     Volume 2558 
     Issue 388 
     Month กุมภาพันธ์
     Year of Publication 2015 
     Page 601-612 
     Abstract Resistance to chemotherapy is the major problem in cancer treatment. Cholangiocarcinoma (CCA) is the tumor arising from the bile duct epithelium. The disease is characterized by very poor prognosis and rarely responds to current radiotherapy or chemotherapy. Transcription factor Nrf2 is activated by oxidative stress and electrophiles and contributes to cytoprotection in normal cells as well as cancer cells. Inhibition of Nrf2 can enhance the sensitivity of cancer cells to chemotherapeutic agents, although this sensitizing effect is variable depending on the cancers. In this study, we selected three CCA cell lines with different Nrf2 expression levels, detected by immunocytofluorescent staining. Chemotherapeutic agents variably induced the expression of antioxidant and xenobiotic metabolizing genes including Nrf2, NQO1, HO-1, GCLC, and GSTP1. Knockdown of Nrf2 expression by siRNA suppressed protein expression of Nrf2-regulated genes and enhanced the sensitivity to 5-fluorouracil and gemcitabine of CCA cells in both high and low basal Nrf2 expression. Cells with more resistance to chemotherapeutic agents gained more chemosensitizing effect by Nrf2 inhibition than the sensitive cells. The IC50 of the chemotherapeutic agents was also significantly reduced and the maximal cytotoxic effect was increased. Suppression of Nrf2 signaling may be a strategy to increase the efficacy of chemotherapy to CCA. 
     Keyword Nrf2 . Cholangiocarcinoma . Chemosensitizing . Chemotherapeutic agents . Antioxidant . Drug-metabolizing enzyme 
Author
547070027-6 Miss PAPAVEE SAMATIWAT [Main Author]
Medicine Doctoral Degree

Reviewing Status มีผู้ประเมินอิสระ 
Status ตีพิมพ์แล้ว 
Level of Publication นานาชาติ 
citation false 
Part of thesis true 
Attach file
Citation 0